U.S. Markets closed

Can Fred's Strategies Help It Counter Slow Comps & Traffic?

Zacks Equity Research
Walmart (WMT) closed the most recent trading day at $95.84, moving +0.09% from the previous trading session.

The retail segment has been witnessing increased competition owing to technological upgradations and continuous expansion efforts by large retailers. Consumers are increasingly shifting toward online shopping, thereby hurting store traffic. As a result, smaller firms in the segment, who are incapable of adapting with such changing trends, have resorted to store closures as consumer footfall continues to decline.

Fred's, Inc FRED is one such company that has resorted to store closures amid such challenging retail scenario. Let’s now delve into some of the aspects that have led to the dismal performance of the company.

Declining Comps and Store Closure

Fred's has been witnessing sluggish comps, lately, owing to declining store traffic and sale of discontinued inventory. A glance at the comps’ performance over the past four months reveals that, while comps were up 0.8% for during May, the same declined 1.6%, 0.1% and 0.5% during June, July and August, respectively. In fact, the decline in store traffic led to the closure of 39 stores during the first quarter of 2017. Persisting challenges in the Front Store business and competitive consumable categories had also affected the company’s overall sales figures.

Cancelled Walgreens-Rite Aid Merger

Fred's strategic plans for store expansion were gravely impacted by the cancelled Walgreens Boots Alliance, Inc WBA and Rite Aid Corporation RAD merger on June 30. If the deal was to materialize, it would have positioned Fred’s as the third-largest drugstore chain in the nation after Walgreens and CVS Health Corporation CVS. The professional, legal, banking and integration planning fees iincurred in connection with this deal, have become unyielding and hurt the company’s profit reserves.

Lack of International Exposure

Since the developed markets of Europe, America and Canada are already saturated, most retail companies are looking toward expanding themselves in developing nations such as China, Brazil, India, Mexico and Russia, amongst others. These nations offer great growth opportunity owing to rising population and an affluent middle class. Fred’s, however, is yet to strengthen footprint in these markets.

Final Thoughts

Such ongoing challenges have led Fred’s to deliver weak bottom-line performance over the past five quarters, posting a loss in each of them.

Nevertheless, the company has been making significant advancement with its turnaround strategies that aims at reducing selling, general and administrative expenses and driving free cash flow. The turnaround plans also includes focusing on organization of its pharmacy business, to drive scripts into the stores and improve service to its patients. The company has also been emphasizing on internal reorganization and geographic expansion. However, such efforts are yet to bear significant impacts upon the company’s top-line performance.

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Fred's, Inc. (FRED) : Free Stock Analysis Report
 
Rite Aid Corporation (RAD) : Free Stock Analysis Report
 
CVS Health Corporation (CVS) : Free Stock Analysis Report
 
Walgreens Boots Alliance, Inc. (WBA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research